Annual CFO
-$30.89 M
+$2.93 M+8.67%
31 December 2023
Summary:
Cardiff Oncology annual cash flow from operations is currently -$30.89 million, with the most recent change of +$2.93 million (+8.67%) on 31 December 2023. During the last 3 years, it has fallen by -$14.57 million (-89.32%). CRDF annual CFO is now -1500.11% below its all-time high of -$1.93 million, reached on 31 December 2011.CRDF Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$10.46 M
-$1.23 M-13.28%
30 September 2024
Summary:
Cardiff Oncology quarterly cash flow from operations is currently -$10.46 million, with the most recent change of -$1.23 million (-13.28%) on 30 September 2024. Over the past year, it has dropped by -$2.50 million (-31.41%). CRDF quarterly CFO is now -2561.91% below its all-time high of -$392.80 thousand, reached on 30 September 2011.CRDF Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$34.56 M
-$2.50 M-7.79%
30 September 2024
Summary:
Cardiff Oncology TTM cash flow from operations is currently -$34.56 million, with the most recent change of -$2.50 million (-7.79%) on 30 September 2024. Over the past year, it has dropped by -$1.43 million (-4.31%). CRDF TTM CFO is now -5977.90% below its all-time high of -$568.70 thousand, reached on 31 March 2011.CRDF TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRDF Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +8.7% | -31.4% | -4.3% |
| 3 y3 years | -89.3% | -91.3% | -66.4% |
| 5 y5 years | -134.0% | -228.0% | -154.1% |
CRDF Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -89.3% | +8.7% | -91.3% | at low | -66.4% | at low |
| 5 y | 5 years | -134.0% | +8.7% | -228.0% | at low | -160.5% | at low |
| alltime | all time | -1500.1% | +8.7% | -2561.9% | at low | -5977.9% | at low |
Cardiff Oncology Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$10.46 M(+13.3%) | -$34.56 M(+7.8%) |
| June 2024 | - | -$9.23 M(+19.3%) | -$32.07 M(+7.0%) |
| Mar 2024 | - | -$7.74 M(+8.4%) | -$29.97 M(-3.0%) |
| Dec 2023 | -$30.89 M(-8.7%) | -$7.14 M(-10.3%) | -$30.89 M(-6.8%) |
| Sept 2023 | - | -$7.96 M(+11.6%) | -$33.14 M(+1.4%) |
| June 2023 | - | -$7.13 M(-17.6%) | -$32.67 M(+1.4%) |
| Mar 2023 | - | -$8.66 M(-7.8%) | -$32.23 M(-4.7%) |
| Dec 2022 | -$33.82 M(+46.8%) | -$9.39 M(+25.4%) | -$33.82 M(+6.3%) |
| Sept 2022 | - | -$7.49 M(+11.8%) | -$31.82 M(+6.8%) |
| June 2022 | - | -$6.70 M(-34.7%) | -$29.80 M(+8.7%) |
| Mar 2022 | - | -$10.25 M(+38.7%) | -$27.41 M(+18.9%) |
| Dec 2021 | -$23.04 M(+41.2%) | -$7.39 M(+35.2%) | -$23.04 M(+10.9%) |
| Sept 2021 | - | -$5.46 M(+27.1%) | -$20.77 M(+10.3%) |
| June 2021 | - | -$4.30 M(-26.9%) | -$18.84 M(+0.1%) |
| Mar 2021 | - | -$5.88 M(+14.8%) | -$18.82 M(+15.4%) |
| Dec 2020 | -$16.32 M(+23.0%) | -$5.12 M(+45.3%) | -$16.32 M(+12.8%) |
| Sept 2020 | - | -$3.53 M(-17.8%) | -$14.47 M(+2.4%) |
| June 2020 | - | -$4.29 M(+27.2%) | -$14.13 M(+6.4%) |
| Mar 2020 | - | -$3.37 M(+3.0%) | -$13.28 M(+0.1%) |
| Dec 2019 | -$13.27 M(+0.5%) | -$3.28 M(+2.8%) | -$13.27 M(-2.5%) |
| Sept 2019 | - | -$3.19 M(-7.4%) | -$13.60 M(-2.1%) |
| June 2019 | - | -$3.44 M(+2.5%) | -$13.90 M(+1.4%) |
| Mar 2019 | - | -$3.36 M(-7.0%) | -$13.70 M(+3.8%) |
| Dec 2018 | -$13.20 M(-43.3%) | -$3.61 M(+3.8%) | -$13.20 M(+2.2%) |
| Sept 2018 | - | -$3.48 M(+7.0%) | -$12.92 M(-19.4%) |
| June 2018 | - | -$3.25 M(+13.8%) | -$16.03 M(-7.7%) |
| Mar 2018 | - | -$2.86 M(-14.3%) | -$17.38 M(-25.4%) |
| Dec 2017 | -$23.28 M | -$3.33 M(-49.5%) | -$23.28 M(-19.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2017 | - | -$6.59 M(+43.4%) | -$28.95 M(-1.5%) |
| June 2017 | - | -$4.60 M(-47.5%) | -$29.40 M(-10.6%) |
| Mar 2017 | - | -$8.76 M(-2.7%) | -$32.88 M(+5.9%) |
| Dec 2016 | -$31.04 M(+40.3%) | -$9.00 M(+27.9%) | -$31.04 M(+7.6%) |
| Sept 2016 | - | -$7.04 M(-12.8%) | -$28.84 M(+7.1%) |
| June 2016 | - | -$8.08 M(+16.8%) | -$26.93 M(+10.8%) |
| Mar 2016 | - | -$6.92 M(+1.6%) | -$24.30 M(+9.9%) |
| Dec 2015 | -$22.12 M(+73.8%) | -$6.81 M(+32.7%) | -$22.12 M(+15.3%) |
| Sept 2015 | - | -$5.13 M(-5.7%) | -$19.18 M(+9.9%) |
| June 2015 | - | -$5.44 M(+15.0%) | -$17.45 M(+19.0%) |
| Mar 2015 | - | -$4.73 M(+22.4%) | -$14.66 M(+15.2%) |
| Dec 2014 | -$12.73 M(+73.9%) | -$3.87 M(+13.5%) | -$12.73 M(+18.8%) |
| Sept 2014 | - | -$3.41 M(+28.4%) | -$10.72 M(+13.9%) |
| June 2014 | - | -$2.65 M(-5.2%) | -$9.40 M(+10.8%) |
| Mar 2014 | - | -$2.80 M(+50.9%) | -$8.49 M(+16.0%) |
| Dec 2013 | -$7.32 M(+48.3%) | -$1.85 M(-11.6%) | -$7.32 M(+8.0%) |
| Sept 2013 | - | -$2.10 M(+20.8%) | -$6.78 M(+11.2%) |
| June 2013 | - | -$1.74 M(+6.6%) | -$6.10 M(+7.8%) |
| Mar 2013 | - | -$1.63 M(+23.8%) | -$5.66 M(+14.7%) |
| Dec 2012 | -$4.93 M(+155.6%) | -$1.32 M(-7.2%) | -$4.93 M(+19.2%) |
| Sept 2012 | - | -$1.42 M(+9.3%) | -$4.14 M(+32.9%) |
| June 2012 | - | -$1.30 M(+43.2%) | -$3.12 M(+37.4%) |
| Mar 2012 | - | -$905.10 K(+73.9%) | -$2.27 M(+17.4%) |
| Dec 2011 | -$1.93 M(-7.6%) | -$520.60 K(+32.5%) | -$1.93 M(+36.9%) |
| Sept 2011 | - | -$392.80 K(-12.4%) | -$1.41 M(+38.6%) |
| June 2011 | - | -$448.20 K(-21.2%) | -$1.02 M(+78.8%) |
| Mar 2011 | - | -$568.70 K | -$568.70 K |
| Dec 2010 | -$2.09 M | - | - |
FAQ
- What is Cardiff Oncology annual cash flow from operations?
- What is the all time high annual CFO for Cardiff Oncology?
- What is Cardiff Oncology annual CFO year-on-year change?
- What is Cardiff Oncology quarterly cash flow from operations?
- What is the all time high quarterly CFO for Cardiff Oncology?
- What is Cardiff Oncology quarterly CFO year-on-year change?
- What is Cardiff Oncology TTM cash flow from operations?
- What is the all time high TTM CFO for Cardiff Oncology?
- What is Cardiff Oncology TTM CFO year-on-year change?
What is Cardiff Oncology annual cash flow from operations?
The current annual CFO of CRDF is -$30.89 M
What is the all time high annual CFO for Cardiff Oncology?
Cardiff Oncology all-time high annual cash flow from operations is -$1.93 M
What is Cardiff Oncology annual CFO year-on-year change?
Over the past year, CRDF annual cash flow from operations has changed by +$2.93 M (+8.67%)
What is Cardiff Oncology quarterly cash flow from operations?
The current quarterly CFO of CRDF is -$10.46 M
What is the all time high quarterly CFO for Cardiff Oncology?
Cardiff Oncology all-time high quarterly cash flow from operations is -$392.80 K
What is Cardiff Oncology quarterly CFO year-on-year change?
Over the past year, CRDF quarterly cash flow from operations has changed by -$2.50 M (-31.41%)
What is Cardiff Oncology TTM cash flow from operations?
The current TTM CFO of CRDF is -$34.56 M
What is the all time high TTM CFO for Cardiff Oncology?
Cardiff Oncology all-time high TTM cash flow from operations is -$568.70 K
What is Cardiff Oncology TTM CFO year-on-year change?
Over the past year, CRDF TTM cash flow from operations has changed by -$1.43 M (-4.31%)